HSBC Mutual Fund raised its stake in Vijaya Diagnostic Centre from 2.69% to 3.43%, purchasing 7,63,033 shares.
A leading diagnostic healthcare provider in Southern India, Vijaya Diagnostics Centre operates a network of diagnostic centers and reference laboratories serving patients across multiple cities. The company delivers comprehensive services including nuclear medicine, radiology, laboratory testing, health check-ups, and medical consultations. Its widespread infrastructure and diverse service offerings position it as a prominent player in the diagnostic healthcare sector.
Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.
